Prenatal detection of Canavan disease (aspartoacylase deficiency) by DNA analysis
- 22 March 1994
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 17 (6) , 664-666
- https://doi.org/10.1007/bf00712008
Abstract
Amniocentesis was performed in four pregnancies at risk for Canavan disease (CD). In all families both parents were of Ashkenazi-Jewish origin and harboured the C854 mutation in the cDNA of the aspartoacylase gene. Using DNA analysis of the amniotic cells, three fetuses were predicted to be non-affected and one fetus was predicted to be affected. The concentration ofN-acetylaspartic acid (NAA) in the amniotic fluid was in agreement with these results. In urine samples of the three newborns predicted to be non-affected, the concentration of NAA was normal. Tissues of the aborted fetus were not available. We conclude that DNA analysis is probably a reliable method for prenatal diagnosis of CD.Keywords
This publication has 5 references indexed in Scilit:
- The frequency of the C854 mutation in the aspartoacylase gene in Ashkenazi Jews in Israel.1994
- Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan diseaseNature Genetics, 1993
- Reliable prenatal diagnosis of Canavan disease (aspartoacylase deficiency): Comparison of enzymatic and metabolite analysisJournal of Inherited Metabolic Disease, 1993
- N‐Acetylaspartic aciduria: report of three new cases in children with a neurological syndrome associating macrocephaly and leukodystrophyJournal of Inherited Metabolic Disease, 1988
- Aspartoacylase deficiency and N‐acetylaspartic aciduria in patients with canavan diseaseAmerican Journal of Medical Genetics, 1988